Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$130K Hold
500
0.08% 94
2021
Q3
$132K Hold
500
0.08% 94
2021
Q2
$123K Hold
500
0.07% 96
2021
Q1
$97K Hold
500
0.06% 102
2020
Q4
$106K Hold
500
0.07% 98
2020
Q3
$86K Hold
500
0.06% 100
2020
Q2
$96K Hold
500
0.07% 94
2020
Q1
$74K Hold
500
0.07% 92
2019
Q4
$77K Hold
500
0.06% 98
2019
Q3
$68K Hold
500
0.05% 100
2019
Q2
$61K Hold
500
0.05% 103
2019
Q1
$52K Hold
500
0.04% 109
2018
Q4
$57K Buy
+500
New +$53.6K 0.05% 101

Other funds holding RMD

Truehand Inc's RMD Position: Q4 2021 in Review

Truehand Inc held its ResMed (RMD) position steady in Q4 2021 at 500 shares worth $130K. The position accounts for 0.08% of the portfolio, ranked #94.

Truehand Inc first reported a position in RMD in Q4 2018 and has held it in 13 quarters since. The position peaked at $132K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • Truehand Inc held 500 shares of ResMed worth $130K as of Q4 2021.
  • Truehand Inc left its ResMed share count unchanged in Q4 2021.
  • ResMed made up 0.08% of Truehand Inc's portfolio in Q4 2021, its #94 holding.
  • Truehand Inc first reported a position in ResMed in Q4 2018 and has held it in 13 quarters since.
  • Truehand Inc's ResMed position peaked at $132K in Q3 2021.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.